Here’s Why Sarepta Invested in a Departing Exec’s New Startup
One of Sarepta Therapeutics‘ longtime executives, Alexander “Bo” Cumbo, is leaving the company to launch a new gene therapy company — and... Read More
Sarepta Therapeutics and UF Announce Collaboration to Accelerate the Discovery and Development of Therapies for Rare Genetic Diseases
CAMBRIDGE, Mass., and GAINESVILLE, Fla., Aug. 11, 2020 (GLOBE NEWSWIRE) – Sarepta Therapeutics Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare... Read More
